Ondine Biomedical Inc. (AIM:OBI)

London · Delayed Price · Currency is GBP · Price in GBX

10.21

-0.04 (-0.38%)

Mar 5, 2026, 8:29 AM GMT

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006
aPDT Products	2.05M	1.20M	638.00K	2.57M	1.79M
aPDT Products Growth	70.32%	88.56%	-75.17%	43.44%	16.84%
Total	2.05M	1.20M	638.00K	2.57M	1.79M
Total Growth	70.32%	88.56%	-75.17%	43.44%	16.84%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006
Canada	1.97M	1.12M	596.00K	2.50M	1.75M
Canada Growth	75.18%	88.59%	-76.17%	42.59%	290.93%
Other	80.00K	79.00K	42.00K	68.00K	37.00K
Other Growth	1.27%	88.10%	-38.24%	83.78%	-
Total	2.05M	1.20M	638.00K	2.57M	1.79M
Total Growth	70.32%	88.56%	-75.17%	43.44%	20.17%

Source: S&P Global Market Intelligence.